Regulatory Aspects of Gene Therapy and Cell Therapy Products

Regulatory Aspects of Gene Therapy and Cell Therapy Products
Author :
Publisher : Springer Nature
Total Pages : 243
Release :
ISBN-10 : 9783031345678
ISBN-13 : 3031345673
Rating : 4/5 (673 Downloads)

Book Synopsis Regulatory Aspects of Gene Therapy and Cell Therapy Products by : Maria Cristina Galli

Download or read book Regulatory Aspects of Gene Therapy and Cell Therapy Products written by Maria Cristina Galli and published by Springer Nature. This book was released on 2023-08-01 with total page 243 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book discusses the different regulatory pathways for Advanced Therapy Medicinal Products implemented by national agencies in North and South America, Europe and Asia and by international bodies in the effort of international harmonization. This book represents an update of the first edition, as it covers regulatory novelties and accumulated experience in the regions already addressed. In addition, this new edition offers a wider international perspective: new chapters are included covering Advanced Therapy Medicinal Products regulations in India, Malaysia, Spain and Thailand, the European Pharmacopoeia texts for gene therapy medicinal products as well as international harmonization programs. Each chapter, authored by experts from various regulatory bodies throughout the international community, walks the reader through the applications of nonclinical research to translational clinical research to licensure and therapeutic use of these innovative products. More specifically, each chapter offers insights into fundamental considerations that are essential for developers of Advanced Therapy Medicinal Products in the areas of product quality, pharmacology and toxicology, clinical trial design and HTA pathways, as well as pertinent ‘must-know’ guidelines and regulations. Regulatory Aspects of Gene Therapy and Cell Therapy Products: a Global Perspective is part of the American Society of Gene & Cell Therapy sub-series of the highly successful Advances in Experimental Medicine and Biology series. It is essential reading for graduate students, clinicians, and researchers interested in gene and cell therapy and the regulation of pharmaceuticals.


Regulatory Aspects of Gene Therapy and Cell Therapy Products Related Books

Regulatory Aspects of Gene Therapy and Cell Therapy Products
Language: en
Pages: 243
Authors: Maria Cristina Galli
Categories: Science
Type: BOOK - Published: 2023-08-01 - Publisher: Springer Nature

DOWNLOAD EBOOK

This book discusses the different regulatory pathways for Advanced Therapy Medicinal Products implemented by national agencies in North and South America, Europ
Cell and Gene Therapies
Language: en
Pages: 286
Authors: Miguel-Angel Perales
Categories: Medical
Type: BOOK - Published: 2018-11-27 - Publisher: Springer

DOWNLOAD EBOOK

In this book, experts in the field express their well-reasoned opinions on a range of complex, clinically relevant issues across the full spectrum of cell and g
Regulatory Toxicology
Language: en
Pages: 0
Authors: Franz-Xaver Reichl
Categories: Medical
Type: BOOK - Published: 2014-03-27 - Publisher: Springer

DOWNLOAD EBOOK

This book will be written by experts for professionals, scientists and all those involved in toxicological data generation and decision-making. It is the update
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
Language: en
Pages: 446
Authors: John Geigert
Categories: Medical
Type: BOOK - Published: 2019-05-08 - Publisher: Springer

DOWNLOAD EBOOK

Biopharmaceuticals (i.e., biological medicines sourced from genetically-engineered living systems) for treatment of human diseases have become a significant per
Exploring Novel Clinical Trial Designs for Gene-Based Therapies
Language: en
Pages: 127
Authors: National Academies of Sciences, Engineering, and Medicine
Categories: Medical
Type: BOOK - Published: 2020-08-27 - Publisher: National Academies Press

DOWNLOAD EBOOK

Recognizing the potential design complexities and ethical issues associated with clinical trials for gene therapies, the Forum on Regenerative Medicine of the N